Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis

Resistance toward current and new classes of anti-tuberculosis (anti-TB) antibiotics are rapidly emerging; thus, innovative therapies focused on host processes, termed host-directed therapies (HDTs), are promising novel approaches for shortening therapy regimens without inducing drug resistance. Dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Leukes, Vinzeigh, Walzl, Gerhard, du Plessis, Nelita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109258/
https://www.ncbi.nlm.nih.gov/pubmed/32269568
http://dx.doi.org/10.3389/fimmu.2020.00451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109258/
https://www.ncbi.nlm.nih.gov/pubmed/32269568
http://dx.doi.org/10.3389/fimmu.2020.00451

Ejemplares similares